Publications en collaboration avec des chercheurs de Iuliu Hațieganu University of Medicine and Pharmacy (17)

2024

  1. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

2023

  1. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

2019

  1. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database

    Scandinavian Journal of Rheumatology, Vol. 48, Núm. 1, pp. 42-51

  2. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  3. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

2018

  1. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

    Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834

  2. Gender differences in early systemic sclerosis patients: A report from the EULAR scleroderma trials and research group (EUSTAR) database

    Clinical and Experimental Rheumatology, Vol. 36, pp. S68-S75

2017

  1. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 35, pp. S114-S121

  2. Update of EULAR recommendations for the treatment of systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339

2016

  1. Digital ulcers predict a worse disease course in patients with systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 4, pp. 681-686

2015

  1. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database

    Clinical and Experimental Rheumatology, Vol. 33, pp. 47-54

  2. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 1124-1131

  3. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1262-1269

2011

  1. Is there a role for TNF-α antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 2 SUPPL. 65

  2. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 476-481

2010

  1. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1809-1815

  2. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1488-1501